Skip to main content

Pharmaceutical products need to be as safe as possible and fully compliant with regulatory guidelines. Therefore, in the development of pharmaceutical products, the evaluation of safety and efficacy of these products is mandatory. Several studies need to be performed. These studies are highly regulated and thoroughly monitored, reviewed and evaluated both by Pharming and the regulatory authorities.

Patients vary in their biologicals reactions to pharmaceutical products. This is why not all adverse events (side effects, e.g. allergic reactions) associated with the use of pharmaceutical products can be detected during clinical development, not even by the most comprehensive clinical trials. Capturing as many of these adverse reactions, however rare they may be, from worldwide sources is of paramount importance for continued patient and drug safety (pharmacovigilance).

For Pharming as a global pharmaceutical company, ensuring patient safety is our number one goal, beyond mere compliance with worldwide regulations. By reporting adverse events for Pharming medicinal products you help us to ensure the safety of our products. Your information will also enable Pharming to fulfill its reporting requirements to Health Authorities, which requires that we provide information on adverse events with our products.

 

In case you experience any adverse events following the administration of our product(s): report an adverse event.

To report an adverse event contact Pharming’s Pharmacovigilance department via:

US territories:

Monday to Friday 6.00 a.m. to 4.00 pm (9.00 a.m. to 7.00 p.m. EST)

T: (800) 930-5221

Other territories (e.g. EU):

By phone (24/7 availability) at: +31 (0)71 5247 110

By e-mail at: safety@pharming.com

Pour nous contacter (FR):

France: T: +33-975181134
Luxembourg: T: +352-20881291

 

All the information and personal data you share with us will be protected and kept confidential in line with our company standard operating procedures and applicable national and European data protection regulations. The information you provide will be used for the purpose of drug safety surveillance and to enable us to deal with your report appropriately. To understand how we collect and process your data when you submit an adverse event, please read our Privacy statement

Cookies: This website uses cookies Check the cookies page for more information Accept Decline